Respiri Limited (AU:RSH) has released an update.
Respiri Limited is set to benefit from the American Medical Association’s proposed changes to Remote Patient Monitoring reimbursement criteria, which will enhance patient access and simplify claims for providers. These adjustments are anticipated to significantly increase Respiri’s revenue and patient engagement, as well as reinforce the company’s strategic focus on connected care management. With the changes expected to come into effect in January 2026, Respiri’s innovative healthcare solutions are poised for substantial growth in the US market.
For further insights into AU:RSH stock, check out TipRanks’ Stock Analysis page.
